Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2007; 13(38): 5096-5100
Published online Oct 14, 2007. doi: 10.3748/wjg.v13.i38.5096
Table 1 Main parameters for postoperative pancreatic fistula grading[5]
GradeABC
Clinical conditionsWellOften wellIll appearing/bad
Specific treatment1NoYes/NoYes
US/CTNegativeNegative/PositivePositive
Persistent drainage (after 3 wk)NoUsually yesYes
ReoperationNoNoYes
Death related to fistulaNoNoPossibly yes
Signs of infectionNoYesYes
SepsisNoNoYes
ReadmissionNoYes/NoYes/No
Table 2 Patients’ demographics, indications for surgery, operative and technical factors
No. of patients (%)
Sex
Male30 (47)
Female34 (53)
Indications for surgery
Pancreatic
Cystadenoma19 (30)
Adenocarcinoma11 (17)
Neuroendocrine tumour3 (5)
Cystadenocarcinoma3 (5)
Chronic pancreatitis1 (1.5)
Lymphangioma1 (1.5)
Non-pancreatic
Gastric adenocarcinoma16 (25)
Retroperitoneal sarcoma4 (6)
Colonic adenocarcinoma2 (3)
Renal carcinoma2 (3)
Adrenal grand carcinoma1 (1.5)
Gastrointestinal stromal tumour1 (1.5)
Operations
DP + splenectomy13 (20)
Spleen preserving DP8 (13)
DP + splenectomy + additional procedure43 (67)
Additional procedures
Gastrectomy26 (46)
Colon resection12 (21)
Adrenalectomy10 (17)
Small intestine resection5 (9)
Nephrectomy4 (7)
Closure of pancreatic stump
Stapler29 (45)
Suture35 (55)
Table 3 Postoperative results
No. of patients (%)
Death1 (1.5)
Reoperation2 (3)
Complications
No40 (63)
Yes24 (37)
Pancreatic fistula14 (22)
Grade A4 (28.6)
Grade B9 (64.3)
Grade C1 (7.1)
Intra-abdominal hemorrhage2 (3)
Intra-abdominal abscess3 (5)
Pulmonary5 (8)
Table 4 Incidence of pancreatic fistula after distal pancreatectomy according to examined risk factors
Fistula
Patients(n = 64)No.(n = 50)Yes(n = 14)Pvalue
Age (yr)NS
< 7023 (36)17 (34)6 (43)
> 7041 (64)33 (66)8 (57)
SexNS
Male30 (47)23 (46)7 (50)
Female34 (53)27 (53)7 (50)
Pancreatic stump closureNS
Stapler29 (45)22 (44)7 (50)
Suture35 (55)28 (56)7 (50)
Pathology0.04
Pancreatic disease38 (59)27 (54)11 (79)
Non-pancreatic malignancy26 (41)23 (46)3 (21)
Octreotide therapy0.01
Yes34 (53)30 (60)4 (28)
No30 (47)20 (40)10 (72)
Texture of pancreatic parenchyma0.006
Soft27 (42)15 (30)12 (86)
Fibrotic37 (58)35 (70)2 (14)
Concomitant splenectomy0.002
Yes56 (87)46 (92)10 (71)
No8 (13)4 (8)4 (29)
ProceduresNS
Pancreatic resection only21 (33)14 (28)7 (50)
Additional procedures43 (67)36 (72)7 (50)